Subscribe To
Nanoviricides updates investors on phase 1a/1b trial of antiviral drug candidate for coronavirus
NanoViricides (NYSE-A:NNVC) said it has sufficient funds to complete its ongoing Phase 1a/1b clinical trial of its lead drug ...
October 16, 2023, 9:13 am
Biontech to present multiple program updates across modalities at esmo congress 2023
MAINZ, Germany, October 16, 2023 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present data across its oncology pipeline, c...
October 16, 2023, 3:30 am
Stock split watch: is chipotle next?
Stock splits don't change a company's total value, but they can make shares more affordable. With its shares trading near $1,800, Chipotle has become ...
October 15, 2023, 9:30 am
Alnylam pharmaceuticals: a good buy ahead of phase 3 data for vutrisiran
We rate Alnylam Pharmaceuticals, Inc.'s common stock a Buy on the dip after the complete response letter, CRL for Patisiran. The investment thesis is ...
October 13, 2023, 6:11 pm
Cidara therapeutics and mundipharma receive positive chmp opinion for rezafungin for the treatment of invasive candidiasis in adults(1)
The opinion was based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and e...
October 13, 2023, 2:34 pm
Weekly news summary for october 6 to october 12
Weekly news summary for October 6 to October 12 Friday, Oct. 6: OpenAI Considering In-House AI Chips: Report OpenAI Inc. is reportedly considering dev...
October 13, 2023, 12:59 pm
Us politics - scalise withdrawing from the speaker race. failed to get enough support
Scalise:“I'm withdrawing my name as a candidate for the speaker designee.”Adds that some folks need...
October 13, 2023, 12:01 am
Lantheus: fast-growing radiotherapeutics specialist can benefit from lilly's point biopharma takeover
Lantheus Holdings' stock price has increased more than 1000% since its IPO in 2015, with most gains occurring since 2022. The success of its product P...
October 12, 2023, 4:35 pm
Tonix pharmaceuticals to present at the 2023 thinkequity conference
CHATHAM, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a biopharmaceutical company with marketed produc...
October 12, 2023, 11:00 am
Astria therapeutics strikes exclusive license agreement for dermatitis treatment portfolio
Astria Therapeutics has inked a worldwide exclusive license agreement with Ichnos Sciences for an OX40 portfolio targeting the potential treatment of ...
October 12, 2023, 9:33 am
Eli lilly stock hits new high on positive crohn's disease study results
Eli Lilly and Co (NYSE:LLY) announced on Thursday that its drug development candidate, mirikizumab, m...
October 12, 2023, 8:35 am
Fda finds no misconduct at trial sites for pfizer's lyme disease shot- care access
The U.S. health regulator did not find any misconduct at clinical sites managed by Care Access for Pfizer and French partner Valneva's trial of a Lyme...
October 11, 2023, 1:21 pm
Wall street warms up to tempest as tpst stock surges 1,500%
Tempest Therapeutics (NASDAQ: TPST ) is the stock to watch for today, as its shares are up by a staggering 1,500%. This morning, the cancer therapies ...
October 11, 2023, 12:54 pm
Akero (akro) slumps 63% on mixed results from nash study
Data from a mid-stage study shows that Akero Therapeutics' (AKRO) lead candidate failed to achieve stat...
October 11, 2023, 12:47 pm
Ventyx (vtyx) down despite positive ulcerative colitis study data
Ventyx Biosciences (VTYX) announces positive top-line data from a phase II study evaluating its pipeline candi...
October 11, 2023, 12:47 pm
Patient with candida krusei infection in matinas biopharma’s oral mat2203 expanded access program achieves complete clinical resolution
BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on de...
October 11, 2023, 11:30 am
Is recursion pharmaceuticals stock a buy now?
Recursion Pharmaceuticals is using a novel and promising approach to drug discovery. Its strategy has produced some ...
October 11, 2023, 10:07 am
Nurix (nrix) to report q3 earnings: what's in store?
On Nurix's (NRIX) Q3 earnings call, investors will likely focus on updates related to its pipeline candid...
October 11, 2023, 8:17 am
America's plans for an iss replacement are in peril
The International Space Station will be shut down in early 2031. Over the past week, two leading candid...
October 11, 2023, 7:07 am
Pagegroup falls as recruiter reveals more job offers being rejected by candidates
Shares in PageGroup PLC (LSE:PAGE) fell 5% to 404p after the recruiter reported a worse decline the third quarter than expected, also revealing that...
October 11, 2023, 7:03 am